Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Assets (2023 - 2025)

Cannabis Bioscience International Holdings' Non-Current Assets history spans 3 years, with the latest figure at $2795.0 for Q2 2025.

  • On a quarterly basis, Non-Current Assets fell 92.16% to $2795.0 in Q2 2025 year-over-year; TTM through Feb 2026 was $2795.0, a 97.02% decrease, with the full-year FY2025 number at $2795.0, down 92.16% from a year prior.
  • Non-Current Assets hit $2795.0 in Q2 2025 for Cannabis Bioscience International Holdings, down from $11100.0 in the prior quarter.
  • Over the last five years, Non-Current Assets for CBIH hit a ceiling of $82103.0 in Q4 2023 and a floor of $2795.0 in Q2 2025.
  • Historically, Non-Current Assets has averaged $34751.6 across 3 years, with a median of $25728.5 in 2023.
  • Biggest five-year swings in Non-Current Assets: surged 49.12% in 2024 and later crashed 92.16% in 2025.
  • Tracing CBIH's Non-Current Assets over 3 years: stood at $82103.0 in 2023, then crashed by 76.44% to $19347.0 in 2024, then plummeted by 85.55% to $2795.0 in 2025.
  • Business Quant data shows Non-Current Assets for CBIH at $2795.0 in Q2 2025, $11100.0 in Q1 2025, and $19347.0 in Q4 2024.